Literature DB >> 2237319

The effect of growth factors and synovial fluid on chondrogenesis in perichondrium.

V Skoog1, B Widenfalk, L Ohlsén, A Wasteson.   

Abstract

Reconstruction of cartilage with perichondrium depends on the chondrogenic property of the perichondrial fibrocytes. The present investigation concerns the conditions for the differentiation of fibrocytes into chondrocytes both in vivo and in vitro. For the in vivo studies specimens of rib and auricular perichondrium from adult rabbits were wrapped round silicon rods which were enclosed in dialysis bags. One was placed in the suprapatellar pouch of the knee joint and one was placed intraperitoneally in each rabbit. After two months the bags were extracted, the perichondrium prepared for microscopic examination, and the chondrogenesis evaluated. In vitro the perichondrium was divided into small pieces and incubated with tissue culture medium. The medium was supplemented with fetal calf serum, together with epidermal growth factor, platelet derived growth factor, synovial fluid, or with human serum albumin (control group). After three weeks the explants were prepared for microscopy. Chondrogenesis was judged by the degree of cellular enlargement, capsule formation, deposition of matrix, and activation of the outer fibrocytic layer. In vivo, good cartilage development was found in all specimens placed in the knee joint but, in those placed intraperitoneally, little if any chondrogenesis was seen. In vitro profound differentiation occurred in all cultures supplemented with epidermal growth factor and platelet derived growth factor. An equivalent differentiation was found in perichondrium that had been incubated with synovial fluid. We conclude that the differentiation of perichondrial fibrocytes is initiated in vitro by growth factors. In addition, we have shown that synovial fluid contains factors that promote and enhance the development of cartilage from perichondrium.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2237319     DOI: 10.3109/02844319009004526

Source DB:  PubMed          Journal:  Scand J Plast Reconstr Surg Hand Surg        ISSN: 0284-4311


  7 in total

1.  A 3D system for culturing human articular chondrocytes in synovial fluid.

Authors:  Joshua A Brand; Timothy E McAlindon; Li Zeng
Journal:  J Vis Exp       Date:  2012-01-31       Impact factor: 1.355

2.  The secreted glycoprotein lubricin protects cartilage surfaces and inhibits synovial cell overgrowth.

Authors:  David K Rhee; Jose Marcelino; MacArthur Baker; Yaoqin Gong; Patrick Smits; Véronique Lefebvre; Gregory D Jay; Matthew Stewart; Hongwei Wang; Matthew L Warman; John D Carpten
Journal:  J Clin Invest       Date:  2005-03       Impact factor: 14.808

3.  Compound heterozygous loss of Ext1 and Ext2 is sufficient for formation of multiple exostoses in mouse ribs and long bones.

Authors:  Beverly M Zak; Manuela Schuksz; Eiki Koyama; Christina Mundy; Dan E Wells; Yu Yamaguchi; Maurizio Pacifici; Jeffrey D Esko
Journal:  Bone       Date:  2011-02-15       Impact factor: 4.398

4.  Osteoarthritic Synovial Fluid and TGF-β1 Induce Interleukin-18 in Articular Chondrocytes.

Authors:  Camila B Carballo; Thiago R P Coelho; Rosenilde C de Holanda Afonso; Jane Cristina de Oliveira Faria; Tercia Alves; Samylla M Monte; Grasiella M Ventura Matioszek; Vivaldo Moura-Neto; José M de Brito
Journal:  Cartilage       Date:  2018-08-27       Impact factor: 4.634

5.  Platelet derived growth factor stimulates chondrocyte proliferation but prevents endochondral maturation.

Authors:  K Kieswetter; Z Schwartz; M Alderete; D D Dean; B D Boyan
Journal:  Endocrine       Date:  1997-06       Impact factor: 3.633

Review 6.  Strategies to Convert Cells into Hyaline Cartilage: Magic Spells for Adult Stem Cells.

Authors:  Anastasiia D Kurenkova; Irina A Romanova; Pavel D Kibirskiy; Peter Timashev; Ekaterina V Medvedeva
Journal:  Int J Mol Sci       Date:  2022-09-22       Impact factor: 6.208

7.  Treatment of focal degenerative cartilage defects with polymer-based autologous chondrocyte grafts: four-year clinical results.

Authors:  Peter C Kreuz; Sebastian Müller; Christian Ossendorf; Christian Kaps; Christoph Erggelet
Journal:  Arthritis Res Ther       Date:  2009-03-05       Impact factor: 5.156

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.